• PRM134 Regression Methods for Health-Related Quality of Life Data in Longitudinal Settings- Are More Advanced Techniques Really Performing Better?

    Nov 1, 2012, 00:00

  • PRS10 An Analysis of Reported Pneumonia Deaths in Malaysia

    Nov 1, 2012, 00:00

  • PCN65 Cost-Effectiveness Analysis of Introducing HPV Vaccines in Colombian Women

    Nov 1, 2012, 00:00

  • PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

    Nov 1, 2012, 00:00

  • PHP49 Irrational Use of Antibiotics in Children by Medical Prescribers

    Nov 1, 2012, 00:00

  • PCV87 Factors Related to Non-Adherence and Satisfaction for Hypertension Medications- Results From a Novel Patient Registry

    Nov 1, 2012, 00:00

  • PCN50 Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

    Nov 1, 2012, 00:00

  • PHP137 Changes in the Medicines Pricing and Reimbursement Approach in Bulgaria

    Nov 1, 2012, 00:00

  • PHP34 The Clinical Effectiveness and Resource Utilization of Drugs Which Contain Herbal Extracts – the Examples on Silymarin

    Nov 1, 2012, 00:00

  • PIN49 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Elderly Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PGI1 Acne Drug Therapy and the Development of Comorbid Inflammatory Bowel Disease in the United States

    Nov 1, 2012, 00:00

  • PCN36 Vinorelbine in Patients With Non-Small Lung Cancer- Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PSY5 Comparing Brentuximab Vedotin Overall Survival Data to Standard of Care in Patients With Relapsed/Refractory Hodgkin Lymphoma (HL) Post-Autologous Stem Cell Transplant (ASCT)

    Nov 1, 2012, 00:00

  • PCV70 Cost-Effectiveness of Smoking Cessation Interventions in Smokers With Cardiovascular Disease in the Netherlands

    Nov 1, 2012, 00:00

  • PDB28 Cost of Disease and its Relationship With Diabetic Complications in Turkish Patients With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective Study

    Nov 1, 2012, 00:00

  • PCV5 The Effeects of Statins on Blood Presure in Normotensive or Hypertensive Subjects-a Meta-Analysis of 18 Randomized Controlled Trials Involving 5628 Participants

    Nov 1, 2012, 00:00

  • PRM32 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PND64 Quality of Life and Productivity Loss in Patients With Hereditary Angioedema (HAE) in Sweden; Results From a Retrospective Patient Registry Survey Implemented by Sweha-Reg (a Population Based Census of HAE in Sweden)

    Nov 1, 2012, 00:00

  • PCN85 Economic Assessment of the Oncotype DX Breast Cancer Assay

    Nov 1, 2012, 00:00

  • PDB52 Adheren A Real World Retrospective Database Study Among Type 2 Diabetes Patients Treated With Liraglutide or Exenatide

    Nov 1, 2012, 00:00

  • PRM44 Clinical and Comparative Economic Value - A Novel Pharmacoeconomic Analysis Embedded in the Drug Development Process

    Nov 1, 2012, 00:00

  • PMS75 Real-World Utilization Patterns of Rheumatoid Arthritis Medications in the United States- Anti-TNF Monotherapy and Adherence With Non-Biologic DMARDs in Combination with Anti-TNF Therapy

    Nov 1, 2012, 00:00

  • PMS56 Impact of Compliance on Fracture Risk for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • CV1 Cost-Effectiveness of a Nurse Facilitated Self-Management Programme for Heart Failure

    Nov 1, 2012, 00:00

  • PRM55 Third Party Model Validity- A Review and Survey of Face and Internal Validity of Health Economic Models

    Nov 1, 2012, 00:00

  • PHS1 The Effect of Positioning and PNF-Exercise to Postoperative Bleeding After Hip Replacement

    Nov 1, 2012, 00:00

  • PRM126 Choice-Based Valuation of the SF-12v1

    Nov 1, 2012, 00:00

  • PSU27 Liver Transplantation in Familial Amyloid Polyneuropathy in Brazil- Demographic and Clinical Data Compared to FAP World Transplant Registry

    Nov 1, 2012, 00:00

  • PMS3 Improvements in Patient-Reported Pain and Global Disease Activity in Rheumatoid Arthritis Patients After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in Sweden

    Nov 1, 2012, 00:00

  • PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 Placebo

    Nov 1, 2012, 00:00

  • PGI13 Economic Burden and Treatment Patterns of Adult Patients With Chronic Constipation Identified Through Retrospective Database Research

    Nov 1, 2012, 00:00

  • PHP197 Opportunities and Limitations of Sustainability Indices in Satisfying the Needs of Health Technology Purchasers Seeking Objective and Unbiased Indicators of Environmental and Societal Impacts

    Nov 1, 2012, 00:00

  • PCN19 Medical Management of Metastatic Renal Cell Carcinoma, Retrospective Analysis of Real World Data Settings

    Nov 1, 2012, 00:00

  • PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)

    Nov 1, 2012, 00:00

  • PDB20 Safety of Preoperative Vitamin D Replacement in Mild Primary Hyperparathyroidism With Vitamin D Deficiency- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV77 Analysis of Hospital-Specific Drg Payments for Stroke According to United States Medicare Perspective

    Nov 1, 2012, 00:00

  • HT2 Cost-Effectiveness Analysis of Bone Mineral Density Screening Tools

    Nov 1, 2012, 00:00

  • PND5 A Mixed Treatment Comparison of Gabapentin Enacarbil, Pramipexole, Ropinirole and Rotigotine in Moderate-to-Severe Restless Legs Syndrome (RLS)

    Nov 1, 2012, 00:00

  • PND59 Cross-Cultural Validation of the Huntington'S Disease Quality of Life Battery for Carers in France and Italy

    Nov 1, 2012, 00:00

  • PHP151 The Influence of Patient Compliance Arguments in Nice Technology Appraisals

    Nov 1, 2012, 00:00

  • PHP99 Identifying Major Operational Causes and Potential Remedies for Emergency Department Over-Crowding-Crowding

    Nov 1, 2012, 00:00

  • PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology Assessment

    Nov 1, 2012, 00:00

  • PMS6 Disease Burden of Rheumatoid Arthritis in Mainland China- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM13 Overview of PRO Instruments from the PROQOLID Database for Use in Taiwan

    Nov 1, 2012, 00:00

  • PCN135 The Economic Value of Medical Progress, the Case of Cancer in France (1990-2010)

    Nov 1, 2012, 00:00

  • PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over Time

    Nov 1, 2012, 00:00

  • PHP195 Adoption of New Technologies in Twenty Established and Emerging Markets

    Nov 1, 2012, 00:00

  • PIN23 Economic Analysis of Atazanavir as 1st Line Treatment for VIH Patients, on Stable and Sever Health State

    Nov 1, 2012, 00:00

  • PRM44 Increasing Life Expectancy- Implications for Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PIN5 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Community-Acquired Pneumonia (CAP)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • PHP63 Potential Effects of Changes in Pricing Regulations Between 2004 and 2011 on the Turkish Pharmaceutical Industry

    Nov 1, 2012, 00:00

  • PDB23 Economic Impact of Analogue Insulin on Health Expenditure at the Mexican Institute of Social Security in 2012. An Expenditure Reduction Proposal

    Nov 1, 2012, 00:00

  • PRS9 Allergies- Distribution and Perception in the German General Population

    Nov 1, 2012, 00:00

  • PMS24 Direct and Productivity Costs of Rheumatoid Arthritis in the Slovak Republic – Cost-of-Illness Study

    Nov 1, 2012, 00:00

  • PMS53 Association Between Teriparatide Adherence and Health Care Utilization and Costs in Real World United States Kyphoplasty/Vertebroplasty Patients

    Nov 1, 2012, 00:00

  • PCN113 Assessing Health-Related Quality of Life (HRQoL) for Advanced Basal Cell Carcinoma (aBCC) and Basal Cell Carcinoma Nevus Syndrome (BCCNS)- Development of the First Disease-Specific Patient-Reported Outcome (PRO) Questionnaire

    Nov 1, 2012, 00:00

  • PMH1 Antagonistic Drug Prescribing- Cholinesterase Inhibitors and Anticholinergics

    Nov 1, 2012, 00:00

  • PIH42 Effectiveness of a Protocol for Respiratory Syncytial Virus (RSV) Immunoprophylaxis in Pre-Term Infants Born at 34 Weeks Gestation Age

    Nov 1, 2012, 00:00

  • PND55 Multiple Sclerosis Impact Scale (MSIS-29)- Its Validity and Responsiveness in Clinical Trial-Based Subjects

    Nov 1, 2012, 00:00

  • PRS36 Content Validity of Two Symptom Questionnaires for Idiopathic Pulmonary Fibrosis

    Nov 1, 2012, 00:00

  • PRS24 Cost-Effectiveness of Varenicline Compared With Bupropion and NRT (Nicorette) for Smoking Cessation in Austria

    Nov 1, 2012, 00:00

  • PUK3 Evaluation of Medication-Related Problems in Hemodialysis Patients

    Nov 1, 2012, 00:00

  • PSY6 The Prevalence and Treatment Status of Hemophilia in Mainland China- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PMH4 Pharmacoepidemiology of Antidepressants in Elderly Patients- 12 Years of Experience

    Nov 1, 2012, 00:00

  • PHS96 The Impact of the Implementation of NICE Guidance on Venous Thromboembolism Risk Assessment and Patient Safety Across Four Hospitals in England

    Nov 1, 2012, 00:00

  • PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures

    Nov 1, 2012, 00:00

  • PSS27 Do Scars Impact Beyond Just Appearance? A Report of the Content Elicitation (CE) Phase in the Development of the Patient Reported Scar Evaluation Quesionnaire (PR-SEQ)

    Nov 1, 2012, 00:00

  • PRS35 The Economic Burden of HAE- Findings From the HAE Burden of Illness Study in Europe (HAE-BOIS-Europe)

    Nov 1, 2012, 00:00

  • PDB53 Preliminary Results of a Multicenter Observational Study of Treatment Compliance With Free-Combination Versus Fixed Combination Treatment in Type II Diabetes Mellitus Patients in Greece (Less Study)

    Nov 1, 2012, 00:00

  • PDB25 HbA1C Targets for Patients With Type 2 Diabetes- Results of a Systematic Literature Review

    Nov 1, 2012, 00:00

  • PDB38 Cost-Effectiveness of Insulin Detemir in People With Type 2 Diabetes in Romania

    Nov 1, 2012, 00:00

  • PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting

    Nov 1, 2012, 00:00

  • PDB55 The Adaptation of the Injection Pen Assessment Questionnaire for Use in Europe – Validation Results From a Large Multicenter Study of Recombinant Human Growth Hormone Treatment NaÏve Children and Adults

    Nov 1, 2012, 00:00

  • PIH38 Capturing Quality of Life in Conditions with Fluctuating Symptoms

    Nov 1, 2012, 00:00

  • PCV46 The Pharmacoecomomic Analysis of Iloprost in Critical Limb Ischemia

    Nov 1, 2012, 00:00

  • PCN4 Role of 5-Alpha-Reductase Inhibitors, Statins, Aspirin, Nsaids on the Development of Prostate Cancer in Benign Prostatic Hyperplasia Patients-a Population Based Study

    Nov 1, 2012, 00:00

  • CL2 Usefulness of Days Lost Due to Disability As a New Method in Measuring Burden of Adverse Drug Reactions

    Nov 1, 2012, 00:00

  • PRS1 Cost-Utility of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected With Peanut Allergy Compared to Most Used Diagnostics in Selected Asian Markets

    Nov 1, 2012, 00:00

  • PHP17 Role of Subgroup Analyses for Technology Assessment and Coverage Decisions

    Nov 1, 2012, 00:00

  • PHP57 Clinical Effects of Pharmacist Interventions for Polypharmacy in a Geriatric Clinic in Taiwan

    Nov 1, 2012, 00:00

  • PRM42 Multiple Criteria Decision Analysis for Health Technology Assessment

    Nov 1, 2012, 00:00

  • PGI11 Association Between Knowledge and Health Related Quality of Life in Hepatitis B Patients

    Nov 1, 2012, 00:00

  • PHS48 Cost-Effectiveness Analysis of Tolvaptan for Hyponatreamia in South Korea

    Nov 1, 2012, 00:00

  • PHP119 Value and the Multiple Criteria Used in OECD Countries' Medicine Reimbursement Decision-Making Processes Using Health Economic Evidence

    Nov 1, 2012, 00:00

  • CL3 Anticoagulation Control of a Pharmacist Managed Anticoagulation Clinic in a National Referral Centre in Malaysia

    Nov 1, 2012, 00:00

  • PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada)

    Nov 1, 2012, 00:00

  • PCV41 Model Sensitivity Analysis of Venous Thromboembolism Prevention After Total Knee Replacement

    Nov 1, 2012, 00:00

  • PMH8 Cost of Methylphenidate and Atomoxetine Prescribing to Children and Adults in South Africa

    Nov 1, 2012, 00:00

  • PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PMH47 Willingness to Pay for Key Attributes of the new Long Acting Injectable Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • PRM61 External Validation of a Cardio-Vascular Disease Model

    Nov 1, 2012, 00:00

  • PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques

    Nov 1, 2012, 00:00

  • PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

    Nov 1, 2012, 00:00

  • PHP140 Challenges in the Data Collection Regarding Patient Population and Treatment Costs for Non-Drug Interventions Using the Example of Morbus Dupuytren

    Nov 1, 2012, 00:00

  • PMD52 Diagnostics in Cost-Effectiveness Analysis- The Evaluation of the EOS 2D/3D X-Ray Imaging System

    Nov 1, 2012, 00:00

  • PCN60 The Cost Study of Treating mCRC With Bevacizumab Plus Chemotherapy in the Real Clinical Practice in the Czech Republic

    Nov 1, 2012, 00:00

  • PHP160 Benefits of Probabalistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PRM70 What If All Other Things are Not Equal? – Accounting for Future Changes in the Decision Context When Extrapolating Cost-Effectiveness Results Over Time

    Nov 1, 2012, 00:00

  • PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients

    Nov 1, 2012, 00:00

  • PIN82 The Macro-Economic Impact of Reducing Malaria- An Application of a Dynamic General Equilibrium Modelling to Ghana

    Nov 1, 2012, 00:00

  • PHP41 Use of Special Payments to Encourage the Adoption of Innovative Medical Technologies in the English NHS

    Nov 1, 2012, 00:00

  • PND16 Cost-Effectiveness Analysis of Lacosamide as Adjunctive Therapy in Adults With Partial-Onset Seizures in Mexico

    Nov 1, 2012, 00:00

  • PMS51 Work Productivity and Productivity Costs of Patients With Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis in the Czech Republic

    Nov 1, 2012, 00:00

  • PRS33 Factors Affecting Adherence to COPD Therapy in 5EU

    Nov 1, 2012, 00:00

  • PHP32 Understanding Accessibility for New Medicines Entering the Market Since 2007 in Portugal Using Survival Analysis

    Nov 1, 2012, 00:00

  • PIN31 Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia- 2011

    Nov 1, 2012, 00:00

  • PMD13 Projected Economic Impact of Utilizing Fractional Flow Reserve (FFR)-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Interventions (PCI) in Patients With Multivessel Coronary Disease- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PMD80 Preferences for a New Imaging Technique to Detect Breast Cancer

    Nov 1, 2012, 00:00

  • PCN57 Economic Burden of Prostate Cancer in Russia

    Nov 1, 2012, 00:00

  • PCN48 The Cost of Treating Penile Cancer in English Hospitals- Preliminary Results Using the Hospital Episodes Statistics (HES) Database

    Nov 1, 2012, 00:00

  • PCV29 Long-Term Cost-Effectiveness of Ticagrelor in Patients with Acute Coronary Syndrome in Thailand

    Nov 1, 2012, 00:00

  • PDB7 Clinical and Resource Utilization Outcomes- Elderly Type 2 Diabetes Patients Initiating Insulin Pens Versus Vials

    Nov 1, 2012, 00:00

  • PMH54 ADHD Among Adults in Five Western European Countries- An Analysis of National Health and Wellness Survey Data

    Nov 1, 2012, 00:00

  • PRM99 Translation and Validation of Osteoporosis Self-Efficacy Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain

    Nov 1, 2012, 00:00

  • PMS28 Cost-Benefit-Analysis of Thromboprophylaxis With Rivaroxaban and Certoparin-Sodium in Patients After Total Hip or Knee Replacement

    Nov 1, 2012, 00:00

  • PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Algeria

    Nov 1, 2012, 00:00

  • PIN14 Cost of Treatment for Patient With HIV AIDS in Hospital of East Java, Indonesia

    Nov 1, 2012, 00:00

  • PHP104 A Correspondence Analysis of the Patient's Perspective on Shared Decision Making at the Family-Physician Unit

    Nov 1, 2012, 00:00

  • PCV36 Validation 36 and Comparison of the SF-6D and EQ-5D in Chinese Patients With Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PCN32 Treatment Patterns and Outcomes of Melanoma Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PMS79 Evaluation of Current Health Technology Assessments for Rheumatoid Arthritis – an Insight Into the Key Uncertainties Generated by the Available Evidence

    Nov 1, 2012, 00:00

  • PHP72 New Pricing Policies After Initiation of the Health Transformation Programme in Turkey

    Nov 1, 2012, 00:00

  • PRM174 The Need to Conduct Future Research on the Benefit of the Prostate Specific Antigen Screening Test Using the Value of Information Framework

    Nov 1, 2012, 00:00

  • PRM25 Issues and Uncertainties in Combinations of Diagnostic Technologies- A Case Study in Epilepsy Surgery

    Nov 1, 2012, 00:00

  • PGI9 Pharmacoeconomic Evaluation of Antyhelicobacter Therapy of Ulcers Duodenum in Ukraine

    Nov 1, 2012, 00:00

  • PSY13 Pilot Cost Study of Chronic Mieloid Leukemia Therapy

    Nov 1, 2012, 00:00

  • PMH5 Does Participation in a Weight Control Program Also Improve Clinical and Functional Outcomes for Chinese Patients with Schizophrenia Treated with Olanzapine?

    Nov 1, 2012, 00:00

  • PDB32 Outcomes and Perceptions of 4MM Pen Needle Use in Diabetes Patients- Results From a Multi-Center Survey Pilot Study in Hong Kong

    Nov 1, 2012, 00:00

  • PGI32 New Antiviral Drugs for Hepatitis C in Italy- Will it be a Treasure Hunt?

    Nov 1, 2012, 00:00

  • PCV107 Generic Atorvastatin, the Belgian Statin Market and the Cost-Effectiveness of Statin Therapy

    Nov 1, 2012, 00:00

  • PCN10 Risk of Breast Cancer and Statins- A Population-Based Nested Case-Control Study in Chinese Population

    Nov 1, 2012, 00:00

  • PCN32 Quality of Life of Cancer Patients Receiving Capecitabine Monotherapy at Nakhon Pathom Hospital Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PRM36 A Chinese Population-Based Study on Preferences for Health States- How Individual Characteristics Matter?

    Nov 1, 2012, 00:00

  • PMH56 Most Frequently Diagnosed Mental Health Problems in a German Population

    Nov 1, 2012, 00:00

  • PRM118 Methodology for Neuropsychological Assessment Wordlist Adaptation

    Nov 1, 2012, 00:00

  • PND70 Patient Characteristics and Treatment Status in Parkinson'S Disease (PD)

    Nov 1, 2012, 00:00

  • PDB25 Evaluation of Health Care Cost of Diabetes Before and After Counseling in South Indian Community Setup

    Nov 1, 2012, 00:00

  • PHS6 Diagnosis Rates for Alzheimer's Disease in Taiwan in 2005 by Age Using National Health Insurance Claims Data

    Nov 1, 2012, 00:00

  • PCN62 Cost Impact Modeling of Targeted Molecular Profiling in the Treatment of Colon Cancer

    Nov 1, 2012, 00:00

  • PDB28 Economic Evaluation of Vildagliptin As Add-on Therapy to Metformin in Diabetes Mellitus Treatment in China

    Nov 1, 2012, 00:00

  • PRS30 Cost-Effectiveness Analysis of 100% Whey-Based Partially Hydrolyzed Infant Formula Used for Prevention of Atopic Dermatitis in Germany

    Nov 1, 2012, 00:00

  • PUK4 A Cost-Comparison Analysis of Treating Overactive Bladder (OAB) With Fesoterodine, Tolterodine or Solifenacin in Daily Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PND32 Economic Evaluation of Natalizumab for the Treatment of Multiple Sclerosis in Mexico

    Nov 1, 2012, 00:00

  • PCN35 Survival Estimates of Six Major Advanced and Metastatic Solid Tumors in Europe- A Cancer Registry and Literature Review

    Nov 1, 2012, 00:00

  • PRS2 A Retrospective Epidemiologic Review of COPD in Korea

    Nov 1, 2012, 00:00

  • PCN141 Health Care Utilization (HCU) by Breast Cancer (BC) and Non-Hodgkin Lymphoma (NHL) Patients with Chemotherapy Induced Febrile Neutropenia (FN) in the Netherlands

    Nov 1, 2012, 00:00

  • PHP95 Efficiency of Greek Hospitals- Best Practices of Three Top-Performing Hospitals

    Nov 1, 2012, 00:00

  • PMS24 A Systematic Review of Existing Utility Weight Estimates in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PND21 Multiple Sclerosis in Russian Federation- Evaluation of Social and Economical Burden in Real Clinical Practice

    Nov 1, 2012, 00:00

  • PHP8 A Survey of “Joint Working” Between the Pharmaceutical Industry and the National Health Service in the UK

    Nov 1, 2012, 00:00

  • PSU35 Epidemiological Modeling of Patient Survival After Heart Transplantation in Germany

    Nov 1, 2012, 00:00

  • PSU25 Balloon Kyphoplasty Increases Quality of Life in Cancer Patients With Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PCN128 Estimating the Value of Companion Diagnostics- Are the Incentives Right?

    Nov 1, 2012, 00:00

  • PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA

    Nov 1, 2012, 00:00

  • PIH7 Immunization Providers' Cost and Vaccination Cost in Iraq

    Nov 1, 2012, 00:00

  • PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

    Nov 1, 2012, 00:00

  • PCN84 Abiraterone Acetate Versus Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer- An Economic Evaluation in the Greek Health Care Setting

    Nov 1, 2012, 00:00

  • PIN66 Cost Effectiveness Analysis of Vaccination With 13-Valent (PCV13) and 23-Valent (PPV23) Pneumococcal Vaccines for Senior Adults in São Paulo State, Brazil – Public Perspective

    Nov 1, 2012, 00:00

  • PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Confirm Study

    Nov 1, 2012, 00:00

  • PHP116 Orphan Drug Pricing and Access – Current Situation and Future Trends in EU

    Nov 1, 2012, 00:00

  • PHP200 Effective Demand for a Health Literate Health Care System - Evidence from Irish Survey Data

    Nov 1, 2012, 00:00

  • PSY1 Burdens of Psoriasis in the Asia Pacific Region- A Literature Review

    Nov 1, 2012, 00:00

  • PRM20 Empirical Analysis Shows Reduced Cost Data Collection May Be an Efficient Method in Economic Clinicl Trials

    Nov 1, 2012, 00:00

  • PMD83 The Cost Impact of Modifying Patterns of Self-Monitoring of Blood Glucose in an Irish Type 2 Diabetes Cohort

    Nov 1, 2012, 00:00

  • PND6 Economic Burden of Structural-Metabolic Epilepsy in Malaysia

    Nov 1, 2012, 00:00

  • PCN74 Cost Effectiveness of Cyclophosphamide in the Adjuvant Treatment of Breast Cancer in Europe- A Multi-Country Study

    Nov 1, 2012, 00:00

  • PIH22 Clinical Efficacy and Cost-Effectiveness of Human Recombinant Interferon-α2B in Neonatal Infections

    Nov 1, 2012, 00:00

  • CV4 Evaluation of Telemonitoring for Heart Failure Patients With Implantable Defibrillators- The Evolvo (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) Study

    Nov 1, 2012, 00:00

  • CA2 Applying a Value-Based Price Across Different Disease Areas

    Nov 1, 2012, 00:00

  • PHP56 The Role of Antineoplastic and Immunomodulating Agents in Works and Recommendations of Agency for Health Technology Assessment in Poland (AOTM) in Years 2005-2011

    Nov 1, 2012, 00:00

  • PMH58 The Impact of ADHD Medication Attributes on Physician Prescribing Behavior in the EU- Results From Chart-Reviewed Data

    Nov 1, 2012, 00:00

  • PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011

    Nov 1, 2012, 00:00

  • PCN153 Application of Real World Data to Inform a Breast Cancer Decision - Analytic Model in Austria and the U.S - Preliminary Outcomes of Data Collection

    Nov 1, 2012, 00:00

  • PHS63 Patient Perception of an Oral Systemic Anti-Cancer Therapy Homecare Service

    Nov 1, 2012, 00:00

  • PIN81 Perceptions of Hospital Pharmacists Regarding Effective Anti-Malarial Drug Management in Pakistan. A Qualitative Insight

    Nov 1, 2012, 00:00

  • QL3 Simulations of Adaptive Measurement of Change for Health Related Quality of Life Assesments in Chronic Conditions

    Nov 1, 2012, 00:00

  • PHP145 Using an Evidence Database of Previous Nice HTA Decisions to Maximise Re-Review Strategy

    Nov 1, 2012, 00:00

  • PGI4 Assessing the Use of a Harmonic Scalpel in Laparoscopic Cholecystectomy- A Systematic Review of the Evidence

    Nov 1, 2012, 00:00

  • PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision Making

    Nov 1, 2012, 00:00

  • PHP61 Excess Weekend Mortality in Hospitals- A Result of Higher Severity of Illness at the Time of Admissions?

    Nov 1, 2012, 00:00

  • PMS44 Cost-Effectiveness of Alendronate Therapy Forcorticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • CL1 A Novel Method for Calculating Prevalence of Multiple Sclerosis in Australia

    Nov 1, 2012, 00:00

  • PCV86 The Burden of Non-Adherent Prescription Cost Cutting Among Diagnosed Hypertension Patients in Russia

    Nov 1, 2012, 00:00

  • PCN64 Cost-Consequence Analysis (CCA) of the Treatment of Growing Subependymal Giant Cell Astrocytoma (SEGA) Secondary to Tuberous Sclerosis Complex (TSC) in Brazil

    Nov 1, 2012, 00:00

  • PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany

    Nov 1, 2012, 00:00

  • PHP112 Estimating the Probability of a Favorable Assessment of Clinical Benefits for a New Drug in Germany Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PHS71 Health Related Quality of Life of HIV Patients at a Tertiary Care Hospital in Bangalore

    Nov 1, 2012, 00:00

  • PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in Shenyang

    Nov 1, 2012, 00:00

  • PHP22 Off-Label Use of Intravenous Non-Steroidal Anti-Inflammatory Drugs-Ketorolac in a Nationally Representative Population

    Nov 1, 2012, 00:00

  • PHP123 Importance of Health-Related Quality of Life As an Endpoint in Benefit Assessment According to the German AMNOG

    Nov 1, 2012, 00:00

  • PMH24 Cost of Long-Acting Risperidone Injection Versus Long-Acting Paliperidone Palmitate in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PRM27 Evaluating European Data Sources for Assessing Real-World Effectiveness of New Anti-Diabetic Drugs

    Nov 1, 2012, 00:00

  • ME4 Using Discrete Choice Experiments to Value Health States for Economic Evaluation – the SF-6D in Australia

    Nov 1, 2012, 00:00

  • PIN53 The Cost Effectiveness of Maternal and Infant Antiretroviral Regimens to Prevent Vertical Transmission in a Resource Poor Country

    Nov 1, 2012, 00:00

  • PMS66 The Myotonic Dystrophy Type-1 Health Index (MDHI)- An Analysis of its Ability to Differentiate Between Clinically Distinct Populations

    Nov 1, 2012, 00:00

  • PND60 Non-Diabetic Peripheral Neuropathic Pain is Underdiagnosed in GP Practices Although it has High Impact on Patients' Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PHP105 Impact of Clinical Pharmacy Program on Prescription Errors in a Lebanese Institution- A Cost Benefit Analysis

    Nov 1, 2012, 00:00

  • PMH16 Analysis of the Economic Burden and Cost Structure of Schizophrenia in Germany Using Observational Sickness Fund Data

    Nov 1, 2012, 00:00

  • PMD60 The Costs-Effectiveness of 3M™ CobanTM 2 Layer Compression System (Coban 2) for the Treatment of Lymphoedema in the Netherlands

    Nov 1, 2012, 00:00

  • PMD44 Evaluating Strategies for Using DNA Testing to Identify Mucinous Pancreatic Cysts

    Nov 1, 2012, 00:00

  • PRM127 Measuring Quality of Life in Mental Health- Issues and Challenges

    Nov 1, 2012, 00:00

  • PSY7 Societal Burden Associated With Neuropathic Pain in Europe

    Nov 1, 2012, 00:00

  • PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis

    Nov 1, 2012, 00:00

  • PIH18 Clinical Efficacy and Cost-Effectiveness of Additional Immunotherapy in Early-Onset Neonatal Infections

    Nov 1, 2012, 00:00

  • PMD10 Analysis of Costs of Complications for Stroke Prevention in Atrial Fibrillation Patients, Comparing Dose-Adjusted Warfarin to Left Atrial Appendage Closure

    Nov 1, 2012, 00:00

  • PHP11 Time Trends and Determinants of Pharmaceutical Expenditure in China in 1990-2009

    Nov 1, 2012, 00:00

  • PSS8 Non-Interventional Study on the Burden of Illness in Diabetic Macular Edema (DME) in Belgium

    Nov 1, 2012, 00:00

  • PRS18 Systematic Review of Economic Evaluations, Utility Estimates, Resource Utilisation, and Costs in Chronic Idiopathic Urticaria

    Nov 1, 2012, 00:00

  • PND42 Cost-Effectiveness of Onabotulinumtoxin-a for the Prophylaxis of Chronic Migraine

    Nov 1, 2012, 00:00

  • PRM12 Evidence for Validity of a National Patient-Reported Survey in China- The China National Health and Wellness Survey

    Nov 1, 2012, 00:00

  • PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C

    Nov 1, 2012, 00:00

  • PHS10 HbA1c Testing Frequency in Primary Care Diabetes Patients in Germany and in the UK

    Nov 1, 2012, 00:00

  • PCV36 Increasing Costs for German Social Health Insurance (SHI) Funds by Abandonment of Pentaerithrityltetranitrat (PETN) for Patients With Coronary Heart Disease (CHD)? – A Cost Analysis Based on Sick Fund Data

    Nov 1, 2012, 00:00

  • PMS82 US Treatment Patterns in Psoriatic Arthritis Newly Initiated on Etanercept or Adalimumab

    Nov 1, 2012, 00:00

  • PND15 Cost-Effectiveness of Buccolam® (Licensed Oromucosal Midazolam) Compared to Benzodiazepines for the Treatment of Acute Prolonged Epileptic Seizures in Germany

    Nov 1, 2012, 00:00

  • PIH6 Unintentional Exposures to Buprenorphine/Naloxone Tablets and Oral Film among Children Less Than Six Years Old

    Nov 1, 2012, 00:00

  • PUK20 Development of a Patient Adherence Specific Scale for Use in the Management of Benign Prostatic Hyperplasia Patients

    Nov 1, 2012, 00:00

  • PRM36 Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Evolution of Content, Structure, and Functionalities (2002-2012)

    Nov 1, 2012, 00:00

  • PMS38 Cost-Effectiveness of Tapentadol for Severe Chronic Non-Cancer Pain in Belgium

    Nov 1, 2012, 00:00

  • PHP203 How to Optimise Chances for Successful AMNOG Assessments – Best Practice Approach for German Market Access

    Nov 1, 2012, 00:00

  • PSY13 Systematic Review of the Economic and Epidemiological Burden of Bleeding-Related Complications in Hong Kong

    Nov 1, 2012, 00:00

  • PHP118 The Attitude of Farmers to the New Rural Cooperative Medical Scheme in the Northwest of China- A Cross-Sectional Study

    Nov 1, 2012, 00:00

  • PHP1 A Qualitative Exploration of Malaysian Cancer Patients' Perceptions Towards Cancer Screening

    Nov 1, 2012, 00:00

  • PCN148 Review of National Institute for Health and Clinical Excellence (NICE) Recommendations for Anti-Cancer Agents Across Multiple Drug-Indication Combinations

    Nov 1, 2012, 00:00

  • PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies- Problems and Solutions

    Nov 1, 2012, 00:00

  • PCN123 A Conjoint Analysis of Willingness to Pay to Avoid Metastatic Breast Cancer Side Effects

    Nov 1, 2012, 00:00

  • PCN22 Immunotherapy With Sipuleucel-T (APC8015) in Patients With Metastatic Castration-Refractory Prostate Cancer (mCRPC)- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV110 Multivariate Analysis of Clinical and Patient-Level Factors Associated With Colesevelam Treatment Persistence

    Nov 1, 2012, 00:00

  • PHP112 Usage of Self-Monitoring of Blood Glucose (SMBG) by Diabetes Therapy Type in Larger Cities in China

    Nov 1, 2012, 00:00

  • PHP91 Using Observational Comparative Effectiveness Studies to Inform Decision Making- The Need for a Two-Phase Approach to Assessing Quality and Appropriateness

    Nov 1, 2012, 00:00

  • PIN88 Cost Implications of Different Practices in Vaccine Provision

    Nov 1, 2012, 00:00

  • PCN53 Real World Management and Costs in Metastatic Malignant Melanoma (MM) Patients- A Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2012, 00:00

  • PMS60 The Time Horizon Matters- Exploratory Results Varying the Time Horizon in Time Trade-Off and Standard Gamble Utility Elicitation

    Nov 1, 2012, 00:00

  • PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients- An Exploratory Economic Evaluation of Personalized Medicine

    Nov 1, 2012, 00:00

  • PGI5 Increasing Demands for Medical and Drug Utilization in Patients With Long-Term Irritable Bowel Syndrome in Taiwan

    Nov 1, 2012, 00:00

  • PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI- An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)

    Nov 1, 2012, 00:00

  • PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in Boys

    Nov 1, 2012, 00:00

  • PDB56 Development and Validation of Patient Reported Endpoints for T2DM

    Nov 1, 2012, 00:00

  • PSU13 Survival and Cost Comparison of Balloon-Kyphoplasty and Vertebroplasty Using German Claims Data

    Nov 1, 2012, 00:00

  • PHP172 Challenges in Developing a New System for Registration of Patient Registries

    Nov 1, 2012, 00:00

  • PUK22 Evaluating the Minimum Renal Allograft Survival Time Required for Transplantation to Remain Cost Saving in the UK

    Nov 1, 2012, 00:00

  • PCV99 EQ-5D Utilities in Patients Hospitalised With Heart Failure in Canary Islands

    Nov 1, 2012, 00:00

  • PRM146 An Excel Calculator Tool to Perform Meta-Analysis

    Nov 1, 2012, 00:00

  • PMD70 A Five-Year Markov Model Evaluating the Cost-Utility of NASHA/Dx for the Treatment of Fecal Incontinen A United States Perspective

    Nov 1, 2012, 00:00

  • PHP105 Guideline Implementation in Long Term Asthma Management- An Audit Using a Medication Assesssment Tool in Selayang Hospital

    Nov 1, 2012, 00:00

  • PMD8 One Year Evaluation of Effectiveness and Device Complication Outcomes in the Helping Evaluate Reduction in Obesity (HERO) Study

    Nov 1, 2012, 00:00

  • PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

    Nov 1, 2012, 00:00

  • PHP78 Similar HTA, Different Access Outcome? Comparison of Orphan Oncology Drug Assessment in South Korea, Australia and the UK

    Nov 1, 2012, 00:00

  • PRM162 Appropriate Comparative Treatments for Early Benefit Assessment (EBA) in Germany. Comparing the Suggestions by the Joint Federal Committee (GBA) and the Pharmaceutical Companies

    Nov 1, 2012, 00:00

  • PRM23 Discriminative Properties of SF36v2 Health Survey in General Population of Penang State (Malaysia) Using Norm Based Scoring Algorithms

    Nov 1, 2012, 00:00

  • PMH13 Longitudinal Analysis of Patient Level Health Care Costs in Patients With Major Depressive Disorder Treated With Duloxetine

    Nov 1, 2012, 00:00

  • PCN17 Indirect Comparison of the Efficacy of Erlotinib Versus Pemetrexed Plus Cisplatin as First Line Treatment in Patients With Metastatic Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor Activating Mutations

    Nov 1, 2012, 00:00

  • PCV82 Observational Study Evaluating the Level of Compliance With Antihypertensive Drugs in the Greek Population

    Nov 1, 2012, 00:00

  • PSS34 Impact of Specialty on Patient-Physician Interaction and Treatment Patterns- An on-Line Study of Eczema Patients

    Nov 1, 2012, 00:00

  • PMD30 Short Term Health-Economic Outcomes of Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes- A Cost Comparison Analysis

    Nov 1, 2012, 00:00

  • PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland

    Nov 1, 2012, 00:00

  • PSU34 Epidemiological Modeling of Patient Survival After Liver Transplantation in Germany

    Nov 1, 2012, 00:00

  • PHP76 Use of Estimates in the Economic Model of the Impact of New Health Coverage in Private Brazilian Market

    Nov 1, 2012, 00:00

  • PDB30 The Prevalence and Burden of Comorbid Hypertension and Obesity among Patients With Type 2 Diabetes in Japan

    Nov 1, 2012, 00:00

  • PRM26 Comparison of Three Medication Adherence Measures in Patients Taking Warfarin

    Nov 1, 2012, 00:00

  • PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHS25 Direct Medical Costs of Medical Care of Gastrointestinal Bleeding in Mexico

    Nov 1, 2012, 00:00

  • PHS97 An Off-the-Shelf Catalogue of Quality Improvement Interventions to Implement in the Prevention of Pressure Ulcers for Hospital Settings

    Nov 1, 2012, 00:00

  • PHP53 Identification of Factors Affecting the Medicine Expenditures in Public Hospital in Malaysia

    Nov 1, 2012, 00:00

  • PRM145 A Maximum Likelihood Simulation Technique for Estimating Adverse Event Rates From Published Trials

    Nov 1, 2012, 00:00

  • PSU23 Women's Preferences for Breast Reconstruction- A Study Using a Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PMD41 Economic Evaluation of Continuous Subcutaneous Insulin Infusion for Children With Diabetes – a Pilot Study

    Nov 1, 2012, 00:00

  • PHS51 Hospital Stays of Multiple Sclerosis Patients in Germany – Reasons, Frequencies, Duration and Impact on Drug Therapy

    Nov 1, 2012, 00:00

  • PRS45 Health Outcomes and Costs of Patients With Chronic Obstructive Pulmonary Disease According to the Continuity of Ambulatory Care With Korean National Health Insurance Database

    Nov 1, 2012, 00:00

  • PRM18 Modeling Long-Term Health Outcomes in Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PHP22 Pharmacovigilance in Qatar – a Pharmacist Survey

    Nov 1, 2012, 00:00

  • CV3 Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the UK

    Nov 1, 2012, 00:00

  • PHP118 Estimating the Probability of a Recommendation for Reimbursement for a New Drug in the UK Using an MCDA Approach

    Nov 1, 2012, 00:00

  • PHP114 Failure for Cost-Sharing Schemes to Take Off in India- What Can Be the Access Solution?

    Nov 1, 2012, 00:00

  • PGI7 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapies in Ulcerative Colitis (UC)- A UK Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PRM83 Comparing Methods of Mixed Treatment Comparisons in Health Economic Models

    Nov 1, 2012, 00:00

  • PND18 Impact of Co-Morbidities on the Economic Burden of Parkinson'S Disease in Germany Post-2000

    Nov 1, 2012, 00:00

  • PSS22 Impact of Patient Satisfaction on Health Related Quality of Life, in Psoriasis Patients Receiving Traditional Systemic Therapy

    Nov 1, 2012, 00:00

  • PSU14 Economic Impact of Scoliosis in Canada- A RAMQ Database Analysis

    Nov 1, 2012, 00:00

  • PHP13 Affordability of Antibacterial Medicines in Iran During 2001-2010

    Nov 1, 2012, 00:00

  • UT4 Health Utility Scores in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder- Response to Stimulant Treatment

    Nov 1, 2012, 00:00

  • PIH5 Preventable Drug-Related Hospital Visits and Admissions Associated with Laboratory or Physiologic Abnormalities - A Systematic-Review

    Nov 1, 2012, 00:00

  • PCV122 Hypertension and Disability-Free Life Expectancy From a Cohort Study in Japan –Results From a Nationwide Cohort Study (NIPPON DATA80/90)

    Nov 1, 2012, 00:00

  • PHP16 Generic Drug Market Access in Japan

    Nov 1, 2012, 00:00

  • PHP121 Drug Reimbursement Maintenan A French Challenge in 2011

    Nov 1, 2012, 00:00

  • PHS82 Determinants of Health Service Utilization in Urban Pakistan

    Nov 1, 2012, 00:00

  • PSU29 French Survey on the Management of Anemia and Iron Supplementation in Patients in Elective Orthopedic Surgery

    Nov 1, 2012, 00:00

  • PDB11 A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues

    Nov 1, 2012, 00:00

  • PRM77 Mapping the Meanings of Words Patients Use to Describe Their Pain

    Nov 1, 2012, 00:00

  • PHP110 Gaining Reimbursement of Orphan Products in Europe- Challenges Due to Wide Variations in Evidence Requirements and Processes

    Nov 1, 2012, 00:00

  • PCN93 Treatment of Well-Differentiated Pancreatic Neuroendocrine Tumors With Sunitinib in Patients With Disease Progression- Cost-Utility and Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM29 Suprapubic Prostatectomy (SP) Versus Transurethral Endoscopic Resection of Prostate (TURP)- Hospitalization Outcomes and Costs of Benign Prostatic Hyperplasia Using a Prublic Database (DATASUS) in Brazil

    Nov 1, 2012, 00:00

  • CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

    Nov 1, 2012, 00:00

  • PSY35 Assessment of the Most Bothersome Symptoms and Impacts Reported by Patients With Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PHP117 SMC Decisions- Are They Getting Tougher?

    Nov 1, 2012, 00:00

  • MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression

    Nov 1, 2012, 00:00

  • PDB16 Geographic Variation Trends in Diabetes Mellitus Prevalence in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PRM10 Overview of the Prolabels Database Six Years After Its Implementation

    Nov 1, 2012, 00:00

  • PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in Mexico

    Nov 1, 2012, 00:00

  • PND38 Cost Minimization Analysis of Fingolimod Versus Natalizumab in the Second-Line Treatment of Remittent-Recurrent Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PCV74 Economic Evaluation of Cardio Incode, A Genetic Platform for the Assessment of Ischemic Heart Disease Risk

    Nov 1, 2012, 00:00

  • PIN50 A Cost-Effectiveness Analysis of Telaprevir Versus Boceprevir in the Treatment of Hepatitis C- A Greek National Health System Perspective

    Nov 1, 2012, 00:00

  • PSY12 The Cost of Treating Chronic Myeloid Leukemia (CML) in Greece

    Nov 1, 2012, 00:00

  • PSY34 Understanding Disease Presentation and Patient-Reported and Economic Impact of Herpes Zoster (HZ) and Post-Herpetic Neuralgia (PHN)- Findings From the Zoster Quality of Life (ZQOL) Study

    Nov 1, 2012, 00:00

  • PCN49 Economic Burden of Melanoma in Russia

    Nov 1, 2012, 00:00

  • PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada

    Nov 1, 2012, 00:00

  • PSY40 Health-Related Quality of Life and Annual Direct Medical Cost of Patients With Haemophilia B in Fran The EQOFIX Study

    Nov 1, 2012, 00:00

  • PRM178 Excel to Mobile- The Method for Automated Migration of Excel-Based Markov Models to Modern Software Platforms

    Nov 1, 2012, 00:00

  • PMH11 Costs of Children With Attention Deficit Hyperactivity Disorder (ADHD) Being Compliant or Non-Compliant to Pharmacological Treatment- Results From a Dutch Observational Study

    Nov 1, 2012, 00:00

  • PRM89 Standardizing the Metric and Increasing the Efficiency of Physical Functioning Outcomes Measurement

    Nov 1, 2012, 00:00

  • PIN24 Clinical and Economic Evaluation of an Adult Pneumococcal Vaccination Programme Aimed at the Spanish HIV Population

    Nov 1, 2012, 00:00

  • PND1 Prescribing Patterns of Z-Drugs Among Geriatric Patients in a 2000-Bed Medical Center in Taiwan

    Nov 1, 2012, 00:00

  • PIN87 Lengt of Stay and Costs for Patients With Recurrent Clostridium Difficile Infections in Sweden

    Nov 1, 2012, 00:00

  • PRS9 Comparison of Knowledge About Tuberculosis among Libyan and Non Libyan TB Patients in North East Libya

    Nov 1, 2012, 00:00

  • PHS35 The Distribution of Outpatient Physiotherapy Services in Hungary

    Nov 1, 2012, 00:00

  • PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

    Nov 1, 2012, 00:00

  • PGI17 Cost-Effectiveness of Telaprevir With Peginterferon and Ribavirin for Treatment-Naive Patients Chronically Infected With HCV of Genotype 1 in Japan

    Nov 1, 2012, 00:00

  • PIN89 European Reference Pricing for Vaccines in Germany- Mechanics and Effects

    Nov 1, 2012, 00:00

  • PCV9 Association Between Persistence With Statins and Reduction of Low Density Lipoprotein Cholesterol- Analysis of Real-Life Data from Community Settings

    Nov 1, 2012, 00:00

  • PMH2 Value of Agomelatine in the Treatment of Depressive Disorders in Thailand

    Nov 1, 2012, 00:00

  • PHP168 Calculated Forecast for Technical Obsolescence in Computerised Tomography Equipment

    Nov 1, 2012, 00:00

  • PCN7 Angiotensin-Converting Enzyme Inhibitors Enhance the Effect of Cyclooxygenase Inhibitors on Breast Cancer - A Nationwide Case-Control Study

    Nov 1, 2012, 00:00

  • PHP12 Patented Drug Extension Strategies on Health Care Spending- A Cost-Evaluation Analysis

    Nov 1, 2012, 00:00

  • PCV4 Comparative Effectiveness Research of Fondaparinux and Enoxaparin in St-Elevated Acute Coronary Syndrome Patients Receiving Fibrinolytic Therapy- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PRM136 A Utility Single Score Derived From Short Form-36 and Health Assessment Questionnaire in Patients With Antiphospholipid Antibody Syndrome- A Methodolodical Proposal

    Nov 1, 2012, 00:00

  • PMS47 The Health and Economic Consequences of Delay in Starting Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PRM177 What is the Role of Early Health Technology Assessment of Biomarkers in the Pre-Clinical Development Phase? A Reflection on Lessons Learned With Multiple Myeloma

    Nov 1, 2012, 00:00

  • PHS19 Macro-Costing Analysis of Hospital Stay in Heart Failure Patients in Turkish Setting

    Nov 1, 2012, 00:00

  • PMH53 Preventing Alzheimer Disease- Is There a Place for Cost-Effective Interventions? Dynamic Modeling Applied to a Pan European Analysis

    Nov 1, 2012, 00:00

  • PMS81 Cost-Effectiveness and Budget Impact of Certolizumab Pegol Against a Mix of Treatments in an Outcomes-Based Risk-Sharing Scheme in Finland

    Nov 1, 2012, 00:00

  • PIH23 A Discrete Event Simulation Model Used for Pharmacoeconomic Evaluation of Omegaven® in the Chinese Setting

    Nov 1, 2012, 00:00

  • MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment

    Nov 1, 2012, 00:00

  • PSS7 Cost Effectiveness Analysis of Community Screening for Glaucoma in India

    Nov 1, 2012, 00:00

  • PCV32 A Non-Clinical Randomized Controlled Trial Assessing Impact of Pharmacists Led Intervention Programme for Enhancing Medication Adherence and Health-Related Quality of Life

    Nov 1, 2012, 00:00

  • PND13 Budget Impact Analysis and Update of a Cost Effectiveness Evaluation for Alpha (α) Polymorph Rifaximin for the Treatment of Acute Hepatic Encephalopathy

    Nov 1, 2012, 00:00

  • PGI8 Second and Third Generation FVIII Treatment Resources Consumption Break-Even Point- The Pass Study Results

    Nov 1, 2012, 00:00

  • PDB15 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus Throughout the World- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHP11 Availability and Pricing of Innovative Pharmaceuticals in the Top 5 European Pharmaceutical Markets

    Nov 1, 2012, 00:00

  • PRM46 Development of a Framework for Cost-Effectiveness Analysis Cohort Simulation Using an Ordinary Differential Equation Solver Algorithm in R

    Nov 1, 2012, 00:00

  • PDB57 Patients' Preferences for Attributes of Type 2 Diabetes Medications- A Conjoint Analysis

    Nov 1, 2012, 00:00

  • PHP96 Evidence Based Structural Reform in the Provision of Hospital Care- The Case Study of Merging Two Institutions in Hungary

    Nov 1, 2012, 00:00

  • PRS19 Cost-Benefit Analysis of Tiotropium and Salmeterol Treatment Compare to Usual Practice on Sample of Employed Economicaly Active COPD Patients in Ukraine

    Nov 1, 2012, 00:00

  • PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland

    Nov 1, 2012, 00:00

  • PIH51 Review of All Products Authorized by the European Medicines Agency from 1995 to 2011 in Regard to Pediatric Investigation Plan Applications

    Nov 1, 2012, 00:00

  • PCN29 Initial Treatment and Survival Among Elderly Patients With Advanced Breast Cancer by Estrogen Receptor and Progesterone Receptor Status- An Analysis of United States National Registry Data 2000-2009

    Nov 1, 2012, 00:00

  • PRM39 Survival Curve Convergences and Crossing- A Threat to Validity of Meta-Analysis?

    Nov 1, 2012, 00:00

  • PIH1 Spontaneous Adverse Drug Reactions Reporting Forms of 55 Different Countries – Evaluation, Comparison, and Quality Check

    Nov 1, 2012, 00:00

  • PND12 A Cost-Effectiveness Analysis of Self-Administrated Injection of Sumatriptan Succinate for Patients With Severe Migraine in Japan Setting

    Nov 1, 2012, 00:00

  • PND33 Cost-Effectiveness Analysis of Genetic Testing of First-Degree Relatives at Risk of Sudden Cardiac Death Due to Gene-Related Cardiopathies in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PDB31 The Relationship Between the Cost of Disease and the Presence of Ophthalmic Complications in Type 2 Diabetes Mellitus is Determined via the Concomitant Complications Other Than Ophthalmic Complications

    Nov 1, 2012, 00:00

  • PDB27 Cost-Utility Analysis of Liraglutide Versus Glimepiride As Add-on to Metformin in Patients with Type 2 Diabetes in China

    Nov 1, 2012, 00:00

  • PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen

    Nov 1, 2012, 00:00

  • PMH5 Systematic Review and Network Meta-Analysis of Treatments Used for Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PND72 Access, Uptake and Utilization Management of Multiple Sclerosis Products in the United States

    Nov 1, 2012, 00:00

  • PIH9 Assosiation Between Health Care Providers and Immunization Compliance in Iraq

    Nov 1, 2012, 00:00

  • PCV113 The Utilisation of Statins in Slovak Republic

    Nov 1, 2012, 00:00

  • PIN77 Elicitation of Health-Related Quality of Life Concepts Associated With Cytomegalovirus in Transplant Recipients

    Nov 1, 2012, 00:00

  • PGI15 Comparison of Knowledge, Attitude and Practice Among Hepatitis-B Patients and Healthy Population Regarding Hepatitis-B

    Nov 1, 2012, 00:00

  • PRM153 Prioritizing Multiple Patient-Relevant Endpoints - a Methodological Comparison of Conjoint Analysis and Analytic Hierarchy Process Considering IQWiG‘s Efficiency Frontier Concept

    Nov 1, 2012, 00:00

  • PCV27 Cost-Effectiveness of Left Atrial Appendage Occlusion Device for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PCN56 Preliminary Results from a Study of Hospital Costs Due to Treatment of Head and Neck Cancers in England

    Nov 1, 2012, 00:00

  • PR2 A Feasibility Study of Preference-Based Health-Related Quality of Life Measures on Patients With Irritable Bowel Syndrom in Taiwan

    Nov 1, 2012, 00:00

  • PHS26 Economic Burden of Seasonal Influenza B in France During Winter 2010-2011

    Nov 1, 2012, 00:00

  • CN2 How Early-Stage Non-Persistence and Non-Adherence to Adjuvant Hormonal Therapy Associated With Postmenopausal Breast Cancer Mortality in Taiwan

    Nov 1, 2012, 00:00

  • PHS8 Use of Health Care Administrative Databases to Estimate Incidence of Foot Complications in Diabetes Patients

    Nov 1, 2012, 00:00

  • PHS56 Evaluation of Telemedicine Program (ITHACA)- Innovation in the Treatment of Arterial Hypertension Increasing the Compliance and Adherence

    Nov 1, 2012, 00:00

  • PRM8 Treatment of Rheumatoid Arthritis – Comparative Effectiveness of Biologics

    Nov 1, 2012, 00:00

  • PND43 Cost-Utility Analysis Patients With Low Back Pain After Treatment Intraosseous Blockades

    Nov 1, 2012, 00:00

  • PND46 Relationship Between Patient Adherence to Treatment and Spanish Hospital Pharmacy'S Unmet Needs for the Management of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PHP84 The Economic Health Value from Rx to OTC Switch in Greece

    Nov 1, 2012, 00:00

  • PCN70 The Cost Effectiveness of Degarelix for the Treatment of Prostate Cancer in the UK

    Nov 1, 2012, 00:00

  • PGI30 Assessment of Practice Patterns and Treatment-Failure Costs Among Patients With Irritable Bowel Syndrome With Constipation- Findings From a Physician Survey Study

    Nov 1, 2012, 00:00

  • PCN30 Treatment Patterns and Outcomes of Breast Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PIH39 Occupational Stress and Burnout- Impact on the Attitudes of Pharmacists in Providing Pharmaceutical Services

    Nov 1, 2012, 00:00

  • PDB50 Health Care Resource Utilization in the Management of Cushing Disease- An Analysis From South-Western Ontario

    Nov 1, 2012, 00:00

  • PDB43 Economic Evaluation of Vildagliptin Compared to Glimepiride as Add-on to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Greece

    Nov 1, 2012, 00:00

  • PSY43 Utilization of Pain Medications in Patients With Chronic Lower Back Pain Who Initiated Duloxetine or Standard of Care for the Management of Pain

    Nov 1, 2012, 00:00

  • PHP201 Can Risk Management Plans (RMP) Contribute to Health Technology Assessment (HTA) and Knowledge of Safety in Everyday Medical Practice?

    Nov 1, 2012, 00:00

  • PUK2 Economic Burden of Hemodialysis and Peritoneal Dialysis in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PCN131 Pricing Theory and Reality- The Link Between Outcomes and Price

    Nov 1, 2012, 00:00

  • PSY4 Studies on Lead Detoxifying Effect of Ascorbic Acid in Traffic Police Subjects of Karachi

    Nov 1, 2012, 00:00

  • PIN74 Cost Savings Due to Antibiotic Prescription Related to Quick C-Reactive Protein Testing

    Nov 1, 2012, 00:00

  • PIN41 Cost-Effectiveness of Pertussis Adolescent Booster in England and Wales- A Dynamic Model Based Analysis

    Nov 1, 2012, 00:00

  • PMD77 Contribution of Individual EQ-5D Dimensions to Improved Quality of Life After Balloon Kyphoplasty for Vertebral Compression Fractures

    Nov 1, 2012, 00:00

  • PDB1 Real-World Incidence of Hypoglycemia and Associated Costs Among Insulin Glargine-Treated Patients With Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2012, 00:00

  • DU3 Market Access Delays for CNS Drugs in Europe

    Nov 1, 2012, 00:00

  • PHP38 Point-of-Care Diagnostic Test Reimbursement and Market Access- Lessons from a Survey of Global Health Technology Assessments

    Nov 1, 2012, 00:00

  • PIN30 Varicella, a Cost of Illness Hungarian Study

    Nov 1, 2012, 00:00

  • PCN89 Cost Effectiveness of Treatment With New 6-Month Leuprorelin Acetate Formulation in Patients With Advanced Prostate Cancer

    Nov 1, 2012, 00:00

  • PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective

    Nov 1, 2012, 00:00

  • PHP116 Equity in the New Rural Cooperative Medical Scheme- Comparison of Benefit Packages for Chronic Disease Outpatients in 32 Counties in China

    Nov 1, 2012, 00:00

  • CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves

    Nov 1, 2012, 00:00

  • PCV34 The Economic Cost of Acute Coronary Syndrome in Turkey

    Nov 1, 2012, 00:00

  • PMD93 Practice Variation in Diagnostic Imaging Workup and Treatment Criteria Following a Recent TIA or Minor Ischemic Stroke- Consequences for Early Economic Evaluations

    Nov 1, 2012, 00:00

  • PND7 Off-Label Use of Antiepileptic Drugs and its Costs – a Drug Utilization Study in Portugal

    Nov 1, 2012, 00:00

  • PA4 Home Dialysis- How High can we go?

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118 (current)
  • 119
  • 120
  • »